40 related articles for article (PubMed ID: 11458980)
1. TNF-alpha and shear stress-induced large artery adaptations.
Ozaki CK; Jiang Z; Berceli SA
J Surg Res; 2007 Aug; 141(2):299-305. PubMed ID: 17574273
[TBL] [Abstract][Full Text] [Related]
2. Cytokines and the early vein graft: strategies to enhance durability.
Ozaki CK
J Vasc Surg; 2007 Jun; 45 Suppl A(Suppl A):A92-8. PubMed ID: 17544029
[TBL] [Abstract][Full Text] [Related]
3. Immunology of cutaneous vasculitis associated with both etanercept and infliximab.
Srivastava MD; Alexander F; Tuthill RJ
Scand J Immunol; 2005 Apr; 61(4):329-36. PubMed ID: 15853915
[TBL] [Abstract][Full Text] [Related]
4. Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial.
D'Haens G; Swijsen C; Noman M; Lemmens L; Ceuppens J; Agbahiwe H; Geboes K; Rutgeerts P
Am J Gastroenterol; 2001 Sep; 96(9):2564-8. PubMed ID: 11569676
[TBL] [Abstract][Full Text] [Related]
5. Development of Crohn's disease in a patient taking etanercept.
Oh J; Arkfeld DG; Horwitz DA
J Rheumatol; 2005 Apr; 32(4):752-3. PubMed ID: 15801037
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
Jang CH; Choi JH; Byun MS; Jue DM
Rheumatology (Oxford); 2006 Jun; 45(6):703-10. PubMed ID: 16418198
[TBL] [Abstract][Full Text] [Related]
7. Development of Crohn's disease following anti-tumour necrosis factor therapy (etanercept).
Yazisiz V; Avci AB; Erbasan F; Yildirim B; Terzioğlu E
Colorectal Dis; 2008 Nov; 10(9):953-4. PubMed ID: 18294265
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effects of etanercept (TNFR:Fc) and its use in a patient with Crohn's disease.
Srivastava MD
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):125-41. PubMed ID: 11458980
[TBL] [Abstract][Full Text] [Related]
9. Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities--the role of bupropion.
Kast RE
Leuk Res; 2005 Dec; 29(12):1459-63. PubMed ID: 15964626
[TBL] [Abstract][Full Text] [Related]
10. Etanercept: An overview.
Goffe B; Cather JC
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S105-11. PubMed ID: 12894133
[TBL] [Abstract][Full Text] [Related]
11. Diverse effects of infliximab and etanercept on T lymphocytes.
Sieper J; Van Den Brande J
Semin Arthritis Rheum; 2005 Apr; 34(5 Suppl1):23-7. PubMed ID: 15852251
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
